Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of ...

Researchers used various sequencing technologies to explore the molecular characteristics of myeloid/natural killer cell precursor acute leukemia (MNKPL). They observed activation of the NOTCH1 and ...

Researchers at The University of Texas MD Anderson Cancer Center have identified why some patients with a rare type of ...

Leukemia refers to cancer of the blood cells and bone marrow. There are four main types, each associated with a different outlook and life expectancy. Healthcare professionals classify the different ...

Targeted drugs have been developed to supplement chemotherapy in the treatment of cancer. These drugs only affect cancer cells, leaving healthy cells alone. Venetoclax is a new targeted therapy option ...

The Food and Drug Administration approved Brukinsa for patients with chronic lymphocytic leukemia or small lymphocytic leukemia. The Food and Drug Administration (FDA) approved Brukinsa (zanubrutinib) ...

Leukemia symptoms include fatigue, weakness, chest pain, shortness of breath, bleeding, bruising, and increased infection risk due to altered blood cell counts. Recent leukemia treatment advancements ...

Acute undifferentiated leukemia is a very rare type of aggressive leukemia — a type of cancer. It’s a very serious condition because researchers don’t know much about it. Leukemia is a type of cancer ...

Getting a diagnosis of leukemia can feel overwhelming. But multiple treatment options and support organizations can help you on your journey after diagnosis. Leukemia is a type of cancer that affects ...

September is Leukemia and Lymphoma Awareness Month. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, myelodysplastic syndromes ...

Leukemia medications kill cancer cells and prevent cancer cells from dividing and multiplying. Leukemia medications may include chemotherapy, targeted therapy, or immunotherapy drugs. Leukemia ...

Researchers have identified a possible new targeted drug for treating acute myeloid leukemia. In the future, the discovery may help patients with certain rare subtypes of the disease. Targeted drugs ...